Senti Bio announces multiple data presentations at SITC meeting

Senti Biosciences announced four poster presentations at the Society for Immunotherapy of Cancer, SITC, Annual Meeting, being held November 1-5, 2023, in San Diego, CA. “This continues to be a definitive year for Senti with multiple presentations across multiple medical and scientific venues,” said Timothy Lu, MD, PhD, Chief Executive Officer and Co-Founder of Senti Bio. “The four posters at this year’s SITC meeting highlight the breadth and modularity of our platform. We also continue to make progress with our longstanding partner BlueRock, as highlighted by our two joint posters. Overall, I am pleased with the growing interest in our Gene Circuit platform throughout the global scientific community as we soon embark on using these technologies in the clinic.”